Chondroitinase ABCI (cABCI) is a drug enzyme that can be used to treat spinal cord injuries. Due to low thermal stability of cABCI, this enzyme was immobilized on Fe 3 O 4 nanoparticle to increase its thermal stability. The size and morphology, structure and magnetic property of the Fe 3 O 4 nanoparticles were characterized by the analyses of SEM, XRD and VSM, respectively, and FTIR spectroscopy was employed to confirm the immobilization of cABCI on the surface of Fe 3 O 4 nanoparticles. The results indicated that the optimum conditions for pH, temperature, cABCI-to-Fe 3 O 4 mass ratio and incubation time in immobilization process were 6.5, 15 C, 0.75 and 4.5 h, respectively, and about 0.037 mg cABCI was bound to 1 mg of Fe 3 O 4 nanoparticles at these conditions. The value of V max was the same for free and immobilized cABCI, but K m value for immobilized cABCI was 1.6 times higher than that for free one. The storage stability of immobilized cABCI was significantly enhanced at low temperatures, e.g. free cABCI retained 19% of its activity after six days at-20 C, while the immobilized one retained 96% of its activity. In vitro release of cABCI from Fe 3 O 4 particles showed that about 94% of the enzyme was released after 6 h.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.